Skip to main content
. 2019 Dec 11;8(24):e013404. doi: 10.1161/JAHA.119.013404

Figure 3.

Figure 3

Follow‐up of ischemic cardiac death according to low‐dose aspirin use in high‐risk participants. Race/ethnicity‐stratified Kaplan–Meier curves illustrating cumulative incidence of ischemic cardiac death during follow‐up according to low‐dose aspirin use. Results are presented for participants in the Framingham 10‐year high‐risk category (≥10%) aged 50 to 69 years or 50 to 59 years, for whom the use of low‐dose aspirin may be considered for the primary prevention of CVD according to the US Preventive Services Task Force 2016 recommendations.